-
Evaluation of neuromyelitis optica spectrum disorder in patients under Rituximab and applicability of no responsiveness criteria for first-line therapies: A real-world data in resources limited settings
-307749 -
Correlations between Multiple Sclerosis, Cognition, Human Development Index, and Social Vulnerability.
-307794 -
DISABILITY FUNCTIONAL PROFILE OF PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS AND ITS ASSOCIATION WITH DISEASE MODIFYING THERAPY IN A HOSPITAL AT NORTHEAST OF BRAZIL
-307799 -
Exit strategies in Natalizumab: the dilemma in limited resource scenarios.
-307816
Publications in other proceedings
-
BCTRIMS 2023
Recurrent drug-induced hepatitis associated with corticosteroids in a patient with multiple sclerosis
-
BCTRIMS 2023
Neuromyelitis Optica Association in Identical Twins: A Case Report and Review of Literature
-
BCTRIMS 2023
Natalizumab treatment in relapsing-remitting multiple sclerosis: a thirteen-year experience in a low prevalence and mixed-race population MS center.
-
BCTRIMS 2023
Bicams as a method of identifying cognitive decline in Multiple Sclerosis patients in a northeast MS reference center
-
BCTRIMS 2023
Prevalence of Clinical Symptoms at First Physiotherapy Assessment of Patients in a MS Reference Center
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
